HEADER CONTRACTILE PROTEIN 14-JUL-23 8PTS TITLE HUMAN GUK1 IN COMPLEX WITH COMPOUND AT8001 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GUANYLATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GMP KINASE,GUANYLATE KINASE 1; COMPND 5 EC: 2.7.4.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GUK1, GMK, GMPK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS COMPLEX INTERMEDIATE COMPOUND INHIBITOR, KINASE, GUANYLATE KINASE, KEYWDS 2 CONTRACTILE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.ZIMBERGER,B.CANARD,F.FERRON REVDAT 2 04-SEP-24 8PTS 1 JRNL REVDAT 1 24-JUL-24 8PTS 0 JRNL AUTH A.CHAZOT,C.ZIMBERGER,M.FERACCI,A.MOUSSA,S.GOOD, JRNL AUTH 2 J.P.SOMMADOSSI,K.ALVAREZ,F.FERRON,B.CANARD JRNL TITL THE ACTIVATION CASCADE OF THE BROAD-SPECTRUM ANTIVIRAL JRNL TITL 2 BEMNIFOSBUVIR CHARACTERIZED AT ATOMIC RESOLUTION. JRNL REF PLOS BIOL. V. 22 02743 2024 JRNL REFN ESSN 1545-7885 JRNL PMID 39190717 JRNL DOI 10.1371/JOURNAL.PBIO.3002743 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.CHAZOT,C.ZIMBERGER,M.FERACCI,A.MOUSSA,S.GOOD, REMARK 1 AUTH 2 J.P.SOMMADOSSI,K.ALVAREZ,F.FERRON,B.CANARD REMARK 1 TITL THE ACTIVATION CHAIN OF THE BROAD-SPECTRUM ANTIVIRAL REMARK 1 TITL 2 BEMNIFOSBUVIR AT ATOMIC RESOLUTION REMARK 1 REF BIORXIV 2024 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2024.02.16.580631 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 (17-FEB-2023) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 37848 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.250 REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3019 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS WERE FULLY REFINED REMARK 3 WITH ZERO OCCUPANCY AT NUCLEAR POSITION. REMARK 4 REMARK 4 8PTS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131907. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5-7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.88560 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37848 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 62.849 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.69900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MORDA REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12 -17 % PEG330 66MM NA CACODYLATE REMARK 280 33MM MES 66MM MGCL2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 66.38650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.13650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 66.38650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.13650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 315 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 196 REMARK 465 ALA A 197 REMARK 465 MET B 1 REMARK 465 THR B 195 REMARK 465 GLY B 196 REMARK 465 ALA B 197 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 27 O HOH B 301 1.81 REMARK 500 N MET A 1 O HOH A 301 1.94 REMARK 500 O HOH B 329 O HOH B 334 2.19 REMARK 500 NH2 ARG A 137 O HOH A 302 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 51 -58.16 -121.26 REMARK 500 ARG A 116 64.88 -116.50 REMARK 500 ARG A 194 59.95 -106.16 REMARK 500 ARG B 137 -88.39 -102.88 REMARK 500 ASN B 138 127.32 -34.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8PTS RELATED DB: PDB DBREF 8PTS A 1 197 UNP Q16774 KGUA_HUMAN 1 197 DBREF 8PTS B 1 197 UNP Q16774 KGUA_HUMAN 1 197 SEQRES 1 A 197 MET SER GLY PRO ARG PRO VAL VAL LEU SER GLY PRO SER SEQRES 2 A 197 GLY ALA GLY LYS SER THR LEU LEU LYS ARG LEU LEU GLN SEQRES 3 A 197 GLU HIS SER GLY ILE PHE GLY PHE SER VAL SER HIS THR SEQRES 4 A 197 THR ARG ASN PRO ARG PRO GLY GLU GLU ASN GLY LYS ASP SEQRES 5 A 197 TYR TYR PHE VAL THR ARG GLU VAL MET GLN ARG ASP ILE SEQRES 6 A 197 ALA ALA GLY ASP PHE ILE GLU HIS ALA GLU PHE SER GLY SEQRES 7 A 197 ASN LEU TYR GLY THR SER LYS VAL ALA VAL GLN ALA VAL SEQRES 8 A 197 GLN ALA MET ASN ARG ILE CYS VAL LEU ASP VAL ASP LEU SEQRES 9 A 197 GLN GLY VAL ARG ASN ILE LYS ALA THR ASP LEU ARG PRO SEQRES 10 A 197 ILE TYR ILE SER VAL GLN PRO PRO SER LEU HIS VAL LEU SEQRES 11 A 197 GLU GLN ARG LEU ARG GLN ARG ASN THR GLU THR GLU GLU SEQRES 12 A 197 SER LEU VAL LYS ARG LEU ALA ALA ALA GLN ALA ASP MET SEQRES 13 A 197 GLU SER SER LYS GLU PRO GLY LEU PHE ASP VAL VAL ILE SEQRES 14 A 197 ILE ASN ASP SER LEU ASP GLN ALA TYR ALA GLU LEU LYS SEQRES 15 A 197 GLU ALA LEU SER GLU GLU ILE LYS LYS ALA GLN ARG THR SEQRES 16 A 197 GLY ALA SEQRES 1 B 197 MET SER GLY PRO ARG PRO VAL VAL LEU SER GLY PRO SER SEQRES 2 B 197 GLY ALA GLY LYS SER THR LEU LEU LYS ARG LEU LEU GLN SEQRES 3 B 197 GLU HIS SER GLY ILE PHE GLY PHE SER VAL SER HIS THR SEQRES 4 B 197 THR ARG ASN PRO ARG PRO GLY GLU GLU ASN GLY LYS ASP SEQRES 5 B 197 TYR TYR PHE VAL THR ARG GLU VAL MET GLN ARG ASP ILE SEQRES 6 B 197 ALA ALA GLY ASP PHE ILE GLU HIS ALA GLU PHE SER GLY SEQRES 7 B 197 ASN LEU TYR GLY THR SER LYS VAL ALA VAL GLN ALA VAL SEQRES 8 B 197 GLN ALA MET ASN ARG ILE CYS VAL LEU ASP VAL ASP LEU SEQRES 9 B 197 GLN GLY VAL ARG ASN ILE LYS ALA THR ASP LEU ARG PRO SEQRES 10 B 197 ILE TYR ILE SER VAL GLN PRO PRO SER LEU HIS VAL LEU SEQRES 11 B 197 GLU GLN ARG LEU ARG GLN ARG ASN THR GLU THR GLU GLU SEQRES 12 B 197 SER LEU VAL LYS ARG LEU ALA ALA ALA GLN ALA ASP MET SEQRES 13 B 197 GLU SER SER LYS GLU PRO GLY LEU PHE ASP VAL VAL ILE SEQRES 14 B 197 ILE ASN ASP SER LEU ASP GLN ALA TYR ALA GLU LEU LYS SEQRES 15 B 197 GLU ALA LEU SER GLU GLU ILE LYS LYS ALA GLN ARG THR SEQRES 16 B 197 GLY ALA HET EIF A 201 40 HET EIF B 201 40 HET GOL B 202 14 HETNAM EIF [(2~{R},3~{R},4~{R},5~{R})-5-(2-AZANYL-6-OXIDANYLIDENE- HETNAM 2 EIF 1~{H}-PURIN-9-YL)-4-FLUORANYL-4-METHYL-3-OXIDANYL- HETNAM 3 EIF OXOLAN-2-YL]METHYL DIHYDROGEN PHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 EIF 2(C11 H15 F N5 O7 P) FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *119(H2 O) HELIX 1 AA1 GLY A 16 HIS A 28 1 13 HELIX 2 AA2 THR A 57 GLY A 68 1 12 HELIX 3 AA3 LYS A 85 MET A 94 1 10 HELIX 4 AA4 ASP A 103 ALA A 112 1 10 HELIX 5 AA5 SER A 126 ASN A 138 1 13 HELIX 6 AA6 THR A 141 SER A 159 1 19 HELIX 7 AA7 SER A 173 ARG A 194 1 22 HELIX 8 AA8 GLY B 16 HIS B 28 1 13 HELIX 9 AA9 THR B 57 ALA B 67 1 11 HELIX 10 AB1 LYS B 85 MET B 94 1 10 HELIX 11 AB2 ASP B 103 ALA B 112 1 10 HELIX 12 AB3 SER B 126 ARG B 137 1 12 HELIX 13 AB4 THR B 141 SER B 159 1 19 HELIX 14 AB5 SER B 173 LEU B 185 1 13 HELIX 15 AB6 LEU B 185 ARG B 194 1 10 SHEET 1 AA1 5 PHE A 32 GLY A 33 0 SHEET 2 AA1 5 ILE A 97 ASP A 101 1 O VAL A 99 N GLY A 33 SHEET 3 AA1 5 VAL A 7 SER A 10 1 N VAL A 7 O LEU A 100 SHEET 4 AA1 5 ILE A 118 GLN A 123 1 O ILE A 120 N VAL A 8 SHEET 5 AA1 5 VAL A 167 ILE A 170 1 O ILE A 169 N SER A 121 SHEET 1 AA2 4 TYR A 54 PHE A 55 0 SHEET 2 AA2 4 HIS A 38 THR A 39 1 N THR A 39 O TYR A 54 SHEET 3 AA2 4 ASN A 79 SER A 84 -1 O GLY A 82 N HIS A 38 SHEET 4 AA2 4 PHE A 70 PHE A 76 -1 N PHE A 76 O ASN A 79 SHEET 1 AA3 5 PHE B 32 GLY B 33 0 SHEET 2 AA3 5 ILE B 97 ASP B 101 1 O VAL B 99 N GLY B 33 SHEET 3 AA3 5 VAL B 7 SER B 10 1 N VAL B 7 O LEU B 100 SHEET 4 AA3 5 ILE B 118 GLN B 123 1 O ILE B 120 N VAL B 8 SHEET 5 AA3 5 VAL B 167 ILE B 170 1 O ILE B 169 N SER B 121 SHEET 1 AA4 4 TYR B 54 PHE B 55 0 SHEET 2 AA4 4 HIS B 38 THR B 39 1 N THR B 39 O TYR B 54 SHEET 3 AA4 4 ASN B 79 SER B 84 -1 O GLY B 82 N HIS B 38 SHEET 4 AA4 4 PHE B 70 PHE B 76 -1 N PHE B 76 O ASN B 79 CRYST1 132.773 54.273 58.957 90.00 108.79 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007532 0.000000 0.002563 0.00000 SCALE2 0.000000 0.018425 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017916 0.00000